UBS raised the price target for the The Chemours Company (NYSE:CC) stock from “a Neutral” to “a Buy”. The rating was released on January 24, 2023, according to finviz. We previously noted in another research note published on January 11, 2023 by BofA Securities that upgraded the stock from a Neutral to a Buy with a price target of $40 for CC stock. The research report from RBC Capital Mkts has downgraded the stock from Outperform to Sector Perform, with a price target set at $33. The stock was initiated by Credit Suisse, who disclosed in a research note on November 01, 2022, to Underperform and set the price objective to $24. In their research brief published October 13, 2022, Goldman analysts initiated the The Chemours Company stock to Neutral with a price target of $30.
The latest trade, Performances and Moving Averages give us the following Picture
The share price of The Chemours Company (NYSE:CC) dipped -8.11% to close Wednesday’s market session at $28.57, lower as compared to yesterday’s close. The stock price fluctuated between $28.275 and $30.22 throughout the trading session with the volume trading being 2302516 shares, which represented a significant variation when compared to the three months average volume of 1.05 million shares. The firm’s stock price fluctuated -16.29% within the last five trades and -18.51% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -18.11% in the last 6 months and -6.39% was subtracted to its value over the previous 3 months. CC stock is trading at a margin of -15.85%, -15.63% and -12.97% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
As of the close of trading, CC deals in the Basic Materials domain. The stock is trading -36.44 percent below its 52-week high and 21.16 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -11.4. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does The Chemours Company’s Profitability and Valuation Ratios Tell Us About the Stock?
With regard to the profitability of the company, the operating margin is currently at 11.50 percent and the profit margin is 8.50 percent, and the company has reported a gross margin of 23.80 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.
The stock’s market cap achieved a total value of $4.44 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for The Chemours Company (NYSE:CC) is 8.02. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 5.26. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 0.65 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 3.87, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.10 percent of The Chemours Company shares are owned by insiders, and 76.70 percent are held by financial institutions. Bellezza Alisha, the President, Thermal Spec Solns at The Chemours Company (CC) has sold 27,716 shares of firm on Mar 06 at a price of $35.47 against the total amount of $0.98 million. In another inside trade, Sparks Edwin C, President, Titan Tech Chem Sol of The Chemours Company (NYSE:CC) sold 22,142 shares of the firm on Jun 07 for a total worth of $0.97 million at a price of $43.59. An inside trade which took place on May 09, SVP, CFO of The Chemours Company Ralhan Sameer sold 20,175 shares of firm against total price of $0.81 million at the cost of $40.01 per share.